Amplicon
Our bioceramic platform makes our tiny, flavor-packed and long-lasting nicotine pouches more satisfying, letting consumers feel more liberated. Together with partners, we intend to help millions of smokers switch to oral nicotine punches.
Emplipharm
We are developing an oral, buccal tablet that delivers buprenorphine with properties that counteract abuse. We are advancing formulation development to increase the initial release profile of buprenorphine after the exploratory pharmacokinetic study of Empli03 showed a steady extended release.
7
Patent families
53
Patents
2014
Founded
Technology for improved experiences
Our products target large and growing markets or significant unmet medical needs.
Our two business areas advance innovative products based on our patented bioceramic platforms and existing and approved molecules and pharmaceutical ingredients.